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It is known strontium can both inhibit the osteoclast formation and stimulate the 
osteoblast maturation, so biomaterials containing this element can favour bone 
structure stabilisation. The addition of Sr to biomaterials could affect their interactions 
with proteins and cells. Here, a silica-hybrid sol-gel network doped with different 
amounts of SrCl2 and applied as coatings on titanium discs was examined. In vitro 
analysis was performed to determine the potential effect of Sr in the coatings, showing 
enhanced gene expression of osteogenic markers (alkaline phosphatase and 
transforming growth factor-β) in MC3T3-E1 incubated with Sr-doped biomaterials. The 
examination of inflammatory markers (tumour necrosis factor-α and interleukin 10) in 
RAW 264.7 macrophages revealed an anti-inflammatory potential of these materials. 
Proteins adsorbed onto the coatings incubated with human serum (3 h at 37 ºC) were 
also analysed; mass spectrometry was used to characterise the proteins adhering to 
materials with different Sr content. Adding Sr to the coatings increased their affinity to 
APOE and VTNC proteins (associated with anti-inflammatory and osteogenic 
functions). Moreover, the proteins involved in coagulation processes, such as 
prothrombin, were more abundant on the coatings containing Sr than on the base sol-
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1. Introduction 
Strontium is a bone-seeking trace metal, found in the bone in relatively small amounts 
(only 3.5% of the Ca content) [1]. It stimulates bone growth and reduces its resorption, 
and has a positive effect on osteogenesis. Even minor quantities of this element can 
help in the stabilisation of bone structure as it inhibits the osteoclast activity and 
stimulates osteoblast maturation [2]. Sr was pointed out on its potential use for 
osteoporosis treatment [3]. In particular, strontium ranelate and strontium chloride have 
been used in osteoporosis to decrease the risk of bone fractures [4].  
The increasing interest in the effect of Sr on bone tissue regeneration has been 
reflected in the design and studies of new Sr-releasing biomaterials [5]. The silica sol-
gel hybrid networks have been showing consistently encouraging results in biomedical 
applications [6]. These materials are bioactive, biocompatible and biodegradable. The 
sol-gel technique makes it easy to produce coated materials, allowing surface 
functionalisation of metal implants such as dental prostheses [7]. Moreover, the 
versatility of the sol-gel method permits the control of the degradation kinetics, making 
the materials of this family perfect candidates for controlled release vehicles [8]. The 
organic-inorganic sol-gel networks have been already used to develop new 
biomaterials that can release Sr, displaying a promising osteogenic behaviour [9–11]. 
In fact, Naruphontjirakul et al. have shown that silica nanoparticles containing Sr could 
be internalised by MC3T3-E1 cells and be capable of promoting cell proliferation and 
mineralisation at certain range of concentrations, with an increase of gene expression 
of osteogenic proteins, as ALP [12]. Moreover, the incorporation of Sr onto bioactive P-
glasses and controlled release has also proven to have an effect on hMSCs 
proliferation and mineralisation, in which is observable an upregulation of early and 
latter osteogenic marker gene expression [13,14]. Although the role of Sr is not well 
elucidated on cell signalling, its influence on cell behaviour is undeniable. 
Immediately after its implantation, a biomaterial begins to interact with surrounding 
tissues and fluids. A complex sequence of events is initiated in a cascade, oriented 
primarily towards the tissue repair and integration of the foreign body into the organism 
or its rejection [15]. One of the first steps in this process is the interaction between the 
biomaterial and bodily fluids, such as the blood. As a result, various proteins adhere to 
the surface of the implant through a competitive displacement mechanism (Vroman 
effect) [16]. The physico-chemical properties of biomaterials, such as surface energy, 
topography, the degree of hydrophilicity and chemical functionalisation, may control the 
surface-protein interactions, depending on the protein affinity. Thus, these biomaterial 
properties will determine the composition, concentration and conformation of the 
protein layer adsorbed to it [17]. The activation and progression of biological processes 
after the implantation is largely dependent on this first layer of proteins formed after 
initial contact with the blood [18]. 
Inflammation processes triggered by the complement system pathway activation and 
the immune cell recruitment become a part of the microenvironment formed after the 
surgical procedure [15]. The specific proteins adhering onto the biomaterial might mark 
the initiation and intensity of this reaction [19]; the composition of the protein layer 
adhering to the biomaterial might be related to its biocompatibility [20]. 
Additionally, the earliest events in tissue repair can be associated with thrombogenesis. 
The thrombus has to grow as an organised structure to seal the wound effectively. It 
also protects the underlying tissue from oxidation, provides a reservoir of mitogens and 
tissue repair mediators and a provisional scaffold for the tissue repair [21]. 
Thus, to ensure the success of implantation, the coagulation and immune and 
inflammatory responses should result in an appropriate response to the foreign body 
implantation, favouring the best possible tissue regeneration and good 
osseointegration [22]. 
The protein layer adsorbed on implant surfaces clearly plays an important role in the 
bone healing process, and the Sr-containing biomaterials are increasingly frequently 
used in various medical applications. Therefore, the effect of strontium incorporation on 
the patterns of the protein binding to such surfaces is of considerable interest and, 
potentially, of significant practical value. Endowing the silica hybrid sol-gel network, 
previously designed by our group [8], with distinct amounts of Sr enables the analysis 
of the effect of incorporating this compound onto protein deposition and consequent 
cellular response. Here, it was assessed the effect of increasing content of Sr on the 
osteogenic potential of these biomaterials and their interactions with immune cells 
(macrophages). Furthermore, mass spectrometry (LC-MS/MS) analysis was conducted 
to identify the protein patterns affected by Sr addition and relative quantification 
approximation. The interactions between the biomaterials, proteins and cells and the 
correlations between gene expression and proteomic results are discussed. 
2. Materials and methods 
2.1. Substrate 
Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially 
available, pure, grade-4 Ti (Ilerimplant-GMI S.L., Lleida, Spain) and then subjected to 
sandblasting and acid-etching (SAE). The discs were abraded with 4-μm aluminium 
oxide particles and acid-etched by submersion in sulfuric acid for 1 h. Then, they were 
washed with acetone, ethanol and 18.2-Ω purified water (20 min in each liquid) in an 
ultrasonic bath and dried under vacuum. Finally, all Ti discs were sterilised using UV 
radiation. 
2.2. Sol-gel synthesis and coating preparation 
The Sr-doped silica-hybrid materials were obtained using the sol-gel route. The 
precursors were the alkoxysilanes methyltrimethoxysilane (M), 3-(glycidoxypropyl)-
trimethoxysilane (G) and tetraethyl orthosilicate (T) (Sigma-Aldrich, St. Louis, MO, 
USA). The molar percentages of these precursors in the material selected as a Sr-
release vehicle were 35 % M, 35 % G and 30 % T, respectively. The material, 
35M35G30T, was chosen on the basis of previous studies [8]. 
Table 1. Chemical compositions of Sr-doped coatings expressed as SrCl2 weight 
percentage. 
Reference Sol-gel network SrCl2 (%) 
0Sr 35M35G30T 0 
0.25Sr 35M35G30T 0.25 
0.5Sr 35M35G30T 0.5 
1Sr 35M35G30T 1 
1.5Sr 35M35G30T 1.5 
 
Table 1 shows the different coating compositions. 2-Propanol (Sigma-Aldrich) was 
used as a solvent in the synthesis, at a volume ratio (alcohol:siloxane) of 1:1. The 
hydrolysis of alkoxysilanes was carried out by adding (at a rate of 1 drop s-1) the 
corresponding stoichiometric amount of aqueous solution of 0.1M HNO3 (Panreac, 
Barcelona, Spain). The solution also contained the required quantities of strontium 
chloride (Sigma-Aldrich). The preparations were kept for 1 h under stirring and then 1 h 
at rest. The samples were prepared immediately afterwards. SAE-titanium was used as 
the substrate for the sol-gel coatings. The coating was performed employing a dip-
coater (KSV DC; KSV NIMA, Espoo, Finland). The discs were immersed in the sol-gel 
solutions at a speed of 60 cm min-1, left immersed for one minute, and removed at a 
100 cm min-1. Moreover, in order to study the Sr liberation, coatings were prepared 
using glass-slides as a substrate. These were previously cleaned in an ultrasonic bath 
(Sonoplus HD 3200) for 20 min at 30 W with nitric acid solution at 25 % volume. 
Following this, the samples were prepared by casting, adding the same amount of sol-
gel in all cases. In order to perform X-ray Diffraction (XRD) analysis, free films of 
materials were obtained by pouring the sol-gel solutions into non-stick Teflon molds. 
Finally, all of the samples were then cured for 2 h at 80 ºC. 
2.3. Physico-chemical characterisation 
The surface topography of the samples was examined using scanning electron 
microscopy (SEM) employing the Leica-Zeiss LEO equipment under vacuum (Leica, 
Wetzlar, Germany). Platinum sputtering was applied to make the materials more 
conductive for the SEM observations. An optical profilometer (interferometric and 
confocal) PLm2300 (Sensofar, Barcelona, Spain) was used to determine the 
roughness. Three discs of each type were tested. Three measurements were 
performed for each disc to obtain the average values of the Ra parameter. The contact 
angle was measured using an automatic contact angle meter OCA 20 (Dataphysics 
Instruments, Filderstadt, Germany). Ten µL of ultrapure water was deposited on the 
disc surfaces at a dosing rate of 27.5 μL s-1 at room temperature. Contact angles were 
determined using SCA 20 software (DataPhysics Instruments). Six discs of each 
material were studied, after depositing two drops on each disc. XRD patterns were 
collected using a Bruker D4-Endeavor diffractometer. Data was collected at room 
temperature in the range of 5–70° (2θ) (step size = 0.05°(2θ), scanning rate = 4 s/step) 
with filtered CuKα radiation (λ = 1.54 A), an operating voltage of 40 kV, and a filament 
current of 40 mA. In order to study the Sr release during time, it was employed the 
inductively coupled plasma mass spectrometer Agilent 7700 Series ICPMS. Sr release 
was assessed using samples submerged in ddH2O at 37 °C for 2 weeks. Aliquots of 
500 μL were taken after 1, 7 and 14 days of immersion.  Each data point is the result of 
average of three individual measurements. 
2.4. In vitro Assays 
2.4.1. Cell culture 
MC3T3-E1 (mouse calvaria osteosarcoma cell line) and RAW 264.7 (mouse murine 
macrophage cell line) were cultured on the Sr-doped discs at a concentration of 1 × 104 
cells/well, in 24-well culture NUNC plates (Thermo Fisher Scientific, Waltham, MA, 
USA). The medium contained DMEM with phenol red (Gibco-Life Technologies, Grand 
Island, NY, USA), 1% 100× penicillin/streptomycin (Biowest Inc., Riverside, KS, USA) 
and 10% fetal bovine serum (FBS) (Gibco-Life Technologies). After incubation for 24 
hours at 37 ºC in a humidified (95%) atmosphere of 5% CO2, the MC3T3-E1 cell line 
medium was replaced with an osteogenic medium composed of DMEM with phenol red 
1×, 1% penicillin/streptomycin, 10% FBS, 1% ascorbic acid (5 mg mL-1) and 0.21% 
β-glycerol phosphate, and incubated again under the same conditions. The culture 
medium was changed every 48 hours. In each plate, a well with cells at the same 
concentration (1 × 104 cells) was used as a control of culture conditions. In parallel, 
cells were allowed to differentiate for 7, 14 and 21 days before being harvested for 
RNA isolation. 
2.4.2.  RNA isolation and cDNA synthesis 
Total RNA was prepared from both cell lines grown on the sol-gel coated titanium 
discs, using Qiagen RNeasy Mini kit (Qiagen, Hilden, Germany), after digestion with 
DNase I (Qiagen), according to the manufacturer’s instructions. The quantity, integrity 
and quality of the resulting RNA were measured using NanoVue® Plus 
Spectrophotometer (GE Healthcare Life Sciences, Little Chalfont, United Kingdom). For 
each sample, about 1 µg of total RNA was converted to cDNA using PrimeScript RT 
Reagent Kit (Perfect Real Time) (TAKARA Bio Inc., Shiga, Japan). The resulting cDNA 
was diluted in DNase-free water to a concentration suitable for reliable RT-PCR 
analysis. 
2.4.3. Quantitative Real-time PCR 
Before the RT-qPCR reaction, the primers for assessing the expression levels of the 
osteogenic markers ALP and TGF-β and inflammatory markers TNF-α and IL-10 were 
designed. To do so, specific DNA sequences for these genes available from NCBI 
(https://www.ncbi.nlm.nih.gov/nuccore) were used, employing the PRIMER3plus 
software tool (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). The 
expression levels were measured using primers purchased from Life Technologies S.A. 
(Gaithersburg, MD). These were: GADPH sense, TGCCCCCATGTTTGTGATG; 
GADPH anti-sense, TGGTGGTGCAGGATGCATT; ALP sense, 
CCAGCAGGTTTCTCTCTTGG; ALP anti-sense, CTGGGAGTCTCATCCTGAGC; 
TGFβ sense, TTGCTTCAGCTCCACAGAGAS; TGFβ anti-sense, 
TGGTTGTAGAGGGCAAGGACD; TNF-α sense, AGCCCCCAGTCTGTATCCTT; TNF-
α anti-sense, CTCCCTTTGCAGAACTCAGG; IL-10 sense, 
CCAAGCCTTATCGGAAATGA and IL-10 anti-sense, TTTTCACAGGGGAGAAATCG. 
The cDNAs from MC3T3-E1 cultures with different materials were used for RT-qPCR 
with the ALP and TGFβ primers. The TNF-α and IL-10 primers were used to assess the 
expression levels in the RAW 264.7 cell culture. All primers are listed from 5′ to 3′. 
GADPH was used as a housekeeping gene to normalise the data obtained from the 
RT-qPCR and calculate the relative fold-change between the conditions. qPCR 
reactions were carried out using SYBR PREMIX Ex Taq (Tli RNase H Plus) (TAKARA 
Bio Inc.), in an Applied Biosystems StepOne Plus™ Real-Time PCR System (Foster 
City, CA, USA). The cycling parameters were as follows: an initial denaturation step at 
95 ºC for 30 s, followed by 95 ºC for 5 s and 60 ºC for 34 s for 40 cycles. The final 
melting curve stage comprised a cycle at 95 ºC for 15 s and at 60 ºC, for 60 s. 
2.5. Adsorbed protein layer 
Sr-doped and non-doped sol-gel biomaterials were incubated for 180 min with 1 mL of 
human blood serum from male AB plasma (Sigma-Aldrich) in a 24-well plate in a 
humidified atmosphere (37 ºC, 5% CO2). The serum was removed, and, to eliminate 
the non-adsorbed proteins, the discs were rinsed five times with ddH2O and once with 
100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The adsorbed protein layer was collected by 
washing the discs in 0.5 M triethylammonium bicarbonate buffer (TEAB), with 4% of 
sodium dodecyl sulphate and 100 mM of dithiothreitol (DTT). Four independent 
experiments were carried out for each type of surface; in each experiment, four discs of 
each material were processed. The protein content was quantified before the 
experiment (Pierce BCA assay kit; Thermo Fisher Scientific), obtaining a value of 49 
mg mL-1. 
2.6. Proteomic analysis 
Proteomic analyses were performed in cuadruplicate as described by Romero-Gavilán 
et al. [23], with minor variations. Briefly, the eluted proteins were in-solution digested, 
following the FASP protocol established by Wisnewski et al. [24], and loaded onto a 
nanoACQUITY UPLC system connected online to an SYNAPT G2-Si MS System 
(Waters, Milford, MA, USA). Differential protein analysis was carried out using 
Progenesis software (Nonlinear Dynamics, Newcastle, UK) as described before [23], 
and the functional annotation of the proteins was performed using DAVID Go 
annotation programme (https://david.ncifcrf.gov/). 
2.7. Statistical analysis 
The data were submitted to one-way analysis of variance (ANOVA) and to a Newman-
Keuls multiple comparison post-hoc test, when appropriate. Differences with p ≤ 0.05 












3.1. Synthesis and physico-chemical characterisation 
The sol-gel synthesis was carried out successfully, and suitable coatings were 
obtained. These adhered well to the substrates, without forming SrCl2 precipitates, as 
can be observed in the SEM micrographs (Figure 1). However, the incorporation of 
more than 1% of SrCl2 in the sol-gel network caused some defects. Figure 1e and 1f 
show small craters in the 1Sr coating and small pores in the 1.5Sr coating. 
 
Figure 1. SEM micrograph of SAE-Ti (a), 0Sr (b), 0.25Sr (c), 0.5Sr (d), 1Sr (e) and 
1.5Sr (f). Scale bar: a-f: 10 µm. 
The sol-gel materials covered the initial SAE roughness on the Ti discs. This caused a 
decrease in Ra parameter obtained using the optical profilometer (Figure 2a). 
However, the Ra value increased significantly when Sr was incorporated (in 
comparison with 35M35G30T formulation). 
 
Figure 2. Roughness (a) and contact angle (b) results. Bars indicate standard 
deviations. Statistical analysis was performed using one-way ANOVA with a Kruskal-
Wallis post-hoc test (***, p < 0.001), showing significant differences in comparison with 
the 35M35G30T base material. 
1Sr and 1.5Sr coatings had the highest Ra values, most likely associated with the 
observed defects (craters and pores). The hydrophilicity of these Sr-doped coatings 
was determined using the contact angle measurements (Figure 2b). The 35M35G30T 
base material displayed a hydrophilic behaviour with a contact angle of approximately 
50º. The addition of SrCl2 to this material caused a significant increase in the contact 
angle (reaching the values between 60º and 70º as more Sr was added), resulting in a 
moderately hydrophilic behaviour. 
The XRD analysis show the amorphous state of the tested sol-gel biomaterials (Figure 
3). On all the formulations it is observable two peaks at ~ 9º and 21º (2θ). The second 
peak is characteristic of the SiO2 network, while the first diffraction peak could be 
related with the incomplete hydrolysis of the precursors [25]. Interestingly, in the 
formulation with more SrCl2 content (1,5Sr), the peak intensity is lower, which can 
suppose a higher cross-linked silica network. No peaks associated to the formation of 
strontium-related crystalline structures were found in the spectra. This is not surprising 
as the temperature used on the heat treatment was 80ºC. Strontium ions are most 




Figure 3. XRD patterns of silica sol-gel 35M35G30T doped with (a) 0SR, (b) 0,25SR, 
(c) 0,5SR, (d) 1SR and (e) 1,5SR. 
 
 
Figure 4 shows the kinetic liberations of Sr2+. It is evident that incorporating more SrCl2 
onto the network causes more Sr to be released. In addition, it is clear an early and 
greater release of Sr on the first 24 hours. After this, the coatings adopt with a steady 
and progressive release even after 14 days of experiment.   
 
Figure 4. Kinetic liberations of Sr2+ from the sol-gel coatings. Mt represents the total 
amount of Sr2+ released from the coatings. Measurements were made at different times 
(1, 7 and 14 days).  
3.2. In vitro assay 
3.2.1. mRNA expression levels 
 
In the MC3T3-E1 cells cultured with the Sr-containing hybrid sol-gel materials, the gene 
expression of osteogenic markers ALP and TGF-β tend to increase for some 
concentrations in comparison with cells grown on the 35M35G30T base material. This 
effect was clearly significant for the 0.25Sr (TGF- β) and 0.5Sr (ALP) samples after 14 
days of culture (Figure 5). 
 
Figure 5. Relative gene expression levels of the osteogenic markers ALP, a), and TGF-
β, b), in the MC3T3-E1 cells cultured on the different Sr-containing coatings. The 
dotted black line represents the control (the well containing cells only, no disc), 
assigned the value of 1 as a reference. The relative mRNA expression was determined 
by RT-PCR after 7 and 14 days of culture. Statistical analysis was performed using 
one-way ANOVA with Kruskal-Wallis post-hoc test (*, p < 0.05; **, p < 0.01). Significant 
differences in expression were found between the cultures grown on Sr-discs and the 
base material (35M35G30T). 
The expression levels of TNF-α, a standard marker of early stages of inflammation, 
decreased significantly (p < 0.001) after 7 days of culture with most of the Sr-
supplemented materials (except for the 1Sr formulation) compared to reference 
sample, indicating that the Sr might decrease the pro-inflammatory effect of the 
35M35G30T base material (Figure 6a). Otherwise, the expression levels of the IL-10, 
one of the main anti-inflammatory markers, increased in the cells grown on all the Sr-
supplemented coatings (Figure 6b). This was observed for both experimental periods 
and was particularly clear after 14 days of culture. 
 
Figure 6. Relative gene expression levels of the inflammatory markers TNF-α, a), and 
IL-10, b), in the RAW 264.7 cells cultured on the different tested formulations. The 
dotted black line represents the control (cells only, no disc), assigned the value of 1 as 
a reference. The relative mRNA expression was determined by RT-PCR after 7 and 14 
days of cell culture. Statistical analysis was performed using one-way ANOVA with a 
Kruskal-Wallis post-hoc test (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Significant 
differences were found for the comparisons with the non-supplemented base material 
(35M35G30T). 
3.3. Proteomic analysis 
The LC-MS/MS analysis identified 136 distinct proteins attached to the studied 
surfaces. Relative protein quantification among the Sr-doped coatings and the base 
sol-gel material was carried out using the Progenesis QI software. The DAVID 
bioinformatics resource and database was employed to classify proteins according to 
their functions. 
Table 2 shows the proteins listed as a result of the Progenesis comparative analysis. 
Two main affinity trends were observed in the patterns of adsorbed proteins depending 
on progressively increasing amounts of SrCl2 incorporated in the material. A group of 
14 proteins (Table 2) was more abundant on Sr-doped coatings than on the control 
coating (0Sr). However, there was also a group of 9 proteins whose surface-binding 
affinity diminished as a result of adding the SrCl2 to the sol-gel network. Among the 
proteins with preferentially increased affinity to Sr-surfaces, the apolipoproteins APOA, 
APOA5 and APOE were associated with lipoprotein metabolic processes by DAVID 
analysis. The CLUS, SAMP, C1QC and C1S were classified as the innate immune 
response proteins. The proteins THRB and FA5 were related to blood coagulation. 
VTNC, DSC1 and PF4V were classified as glycoproteins, and H4 and HBB, as binding 
proteins. 
The proteins CO6 and IGLL5 (also associated with the innate immune response by 
DAVID) were found in smaller amounts on the Sr-coatings than on the non-
supplemented surfaces. KNG1 and FIBA, involved in blood coagulation, and the 
glycoproteins ITIH4 and FHR2 also showed preferential binding to the base-material 
surfaces. Proteins RET4, ALBU and AACT displayed similar behaviour. 
4. Discussion 
Strontium has an important effect on bone metabolism, increasing and maintaining 
bone formation by boosting the osteoblast differentiation and maturation [26] while 
inhibiting bone resorption by osteoclasts [27]. In dental applications, in particular, 
strontium is considered a factor potentially enhancing and shortening the recovery after 
implantation. It is now increasingly used in clinical bone healing treatments, and in 
bone diseases such as osteoporosis [28]. It has also been shown that the first layer of 
proteins adsorbed onto the surfaces after the implantation has a key role in the bone 
healing homeostasis and in the development of inflammatory processes [20]. 
The work presented here examined the effects of incorporating a strontium salt, at 
increasing concentrations, in a specific biomaterial (silica-hybrid sol-gel 35M35G30T) 
on protein adsorption and gene expression in cell cultures. Two cell lines involved in 
specific stages of bone healing were used: a macrophage line associated with the 
initial inflammation after the implantation and an osteoblast line involved in the 
osteogenesis. 
The addition of Sr to a sol-gel network altered the physico-chemical characteristics of 
the base-material surface. It caused an increase in both the contact angle and 
roughness of the surface, probably due to their influence on the sol-gel network 
formation (Figure 2 and 3).  Such changes in the physical and chemical properties 
might alter the affinity between the tested materials and the serum proteins. This would 
affect the protein deposition, and define and condition the initial behaviour of the cells 
involved in the bone healing processes [17]. 
Rechendorf et al. have found that an increase in surface roughness can be associated 
with a rise in total protein adsorption [29]. Nevertheless, the effect of changes in 
roughness on the adsorption of specific proteins is not linear, and the affinities of 
various proteins can be affected differently [30]. Changes in wettability can also affect 
protein adsorption [31]. However, it is difficult to correlate the exact effects of changes 
in these physico-chemical properties on the adsorption of specific proteins when 
complex multi-protein systems, such as human serum, are studied. This is particularly 
true for the studies in which several properties are modified at the same time. 
The proteomic analysis (LC-MS/MS) identified some changes in the patterns of 
proteins attached to the sol-gel, caused by increasing amounts of SrCl2 incorporated 
into the base network material (Table 2). The DAVID bioinformatic tool was used to 
relate these differentially attached proteins to their functions. A cluster of proteins 
involved in the innate immune response was identified; complement proteins C1S and 
C1QC and a pentraxin protein SAMP were more abundant on the materials with more 
than 1% of SrCl2. These proteins have a direct role in the activation of the complement 
cascade pathway [32]. However, the complement protein CO6 and the immunoglobulin 
IGLL5 showed a reduced affinity to the biomaterial surfaces containing Sr compounds. 
The adhesion of this type of proteins to the surface of a biomaterial could initiate an 
immune/inflammatory reaction, which could affect the development of the bone healing 
process [33]. CLUS adsorbed onto Sr-doped coatings in larger amounts than to the Sr-
free materials from 0.5Sr. This protein is related to the regulation of inflammation and 
immunity, such as inhibition of complement cascade [34]. 
The adsorption of some proteins with a role in blood coagulation could also be affected 
by the SrCl2 incorporation into the sol-gel; FA5 and THBR were more abundant on Sr-
containing formulations. Both of these proteins play a role in the coagulation pathway. 
THRB, also known as coagulation factor II, can trigger blood clotting through its 
conversion to the active protease thrombin, activating platelet formation [35]. FA5 has a 
regulatory function in both pro- and anti-coagulant pathways [36]. The KNG1 and ALBU 
proteins tended to be adsorbed less onto the coatings with Sr than onto the base sol-
gel material. The high molecular weight KNG1 belongs to the kallikrein-kinin system, a 
surface-activating coagulation system [37]. FIBA is associated with different biological 
functions, such as blood clotting and fibrinolysis [38]. In contrast, H4, which 
preferentially adhered to the 1.5Sr material, might be associated with the promotion of 
platelet aggregation and thrombosis. However, ALBU has been described as an 
inhibitor of this particular H4 function [39]. It is difficult to predict the final effects of the 
implant surfaces adsorbing various proteins, which might play opposing roles in a living 
organism. The real magnitude of each effect cannot be easily evaluated, and there may 
be some synergistic relationships coming into play. 
Apolipoproteins APOA, APOA5 and APOE showed stronger affinity to Sr-materials and 
differentially adsorbed onto Sr-modified surfaces. This family of proteins have functions 
in lipid metabolism, but they also can prevent the initiation of innate immunity 
processes [40]. The APOE is known for its potent anti-inflammatory effects, resulting 
from its ability to promote macrophage conversion from the pro-inflammatory M1 to the 
anti-inflammatory M2 phenotype [41]. Moreover, this protein could play a role in bone 
metabolism through its effect on the vitamin K uptake into osteoblasts [42] and its 
induction upon mineralization [43]. APOE gene deficiency was also related to the bone 
formation reduction due to the stimulation of p53-mediated osteoblast apoptosis in a 
high-fat diet condition [44]. Additionally, Kim et al. found APOE could play an inhibitory 
role in osteoclast differentiation through the suppression of RANK-dependent activation 
of nuclear factor ҡB and induction of c-Fos and nuclear factor of activated T cell c1 
[45], which might prevent the overstimulation of osteoclastogenesis and its consequent 
excessive bone resorption, involved in bone diseases such as osteoporosis. 
Interestingly, Calciolari et al. studied the proteins and signalling pathways differently 
regulated following a treatment with guide bone regeneration in the calvaria of healthy 
and osteoporotic rats, founding an APOE overexpression in osteoporotic conditions 
[46]. This relationship between APOE with osteoporosis and its greater affinity to Sr-
biomaterials should be further investigated to elucidate the potential of this protein in 
bone regeneration around implants.   
Similarly, the incorporation of SrCl2 increased the affinity of VTNC to the coatings. This 
protein is a known inhibitor of the complement cascade activation (as is CLUS) and 
therefore could regulate the inflammation and immune response [47]. VTNC also 
favours the polarisation to the M2 macrophage phenotype [48]. This is a protein 
involved in the bone metabolism as it can promote the osteogenic differentiation of 
mesenchymal stem cells [49]. Moreover, it is also associated with the coagulation 
system, contributing to thrombus formation, and participates in the vascular 
homoeostasis and tissue regeneration [21]. 
Many of the deposited proteins might play an important role in the bone healing 
processes, and the differences in the physico-chemical properties of the various 
formulations affect their abundance and distribution. It seems reasonable to assume 
that the cell behaviour will also be affected by such changes. Analysis of relative gene 
expression was conducted (using qRT-PCR) for all the tested formulations to examine 
the effect of SrCl2 incorporation on the behaviour of macrophage and osteoblast cells. 
Interestingly, the gene expression of osteogenic markers ALP and TGF-β showed a 
tendency to increase in cells incubated with coatings 0.5Sr and 0.25Sr, respectively, in 
comparison with the 35M35G30T formulation (Figure 5). At the same time, it was 
shown that the greater incorporation of SrCl2 on the network leads to a greater release 
of Sr by the coating, as seen on Figure 4. As seen, the interaction between Sr and cell 
behaviour is not proportional to the Sr release. The effect of Sr on cell differentiation, in 
particular on the synthesis of osteoblastic mRNAs, is well documented. This is 
especially clear in the case of the ALP, where Sr increases the expression of its gene 
in a dose-dependent manner [28]. Sr also enhances the TGF-β expression in 
chondrocytes and osteoblasts, suggesting its active role in bone-cell metabolism and 
activity [50]. It is tempting to assume a correlation between the increased affinity of 
osteogenic reference proteins (such as APOE and VTNC) to Sr-containing coatings 
and the enhanced expression of these markers. The osteogenic potential of Sr-
enriched materials has also been suggested by in vivo studies. Neves et al. have 
reported the effectiveness of Sr-doped biomaterials in stimulation of bone regeneration 
in animal models [5]. Similarly, Shy et al. have concluded that Sr-modified implant 
surfaces have a significantly positive effect on osseointegration in vivo [51]. 
The macrophage mRNA synthesis seems to be affected by the incorporation of SrCl2 
into the base materials. There was a dose-dependent effect, similar to that for the 
osteogenic genes. In this case, a significant decrease was observed in the expression 
of the pro-inflammatory gene TNF-α after 7-day culture with Sr-containing sol-gel 
material (at all concentrations, except for 1Sr; Figure 6a). The gene for the anti-
inflammatory protein IL-10 displays a clear dose-dependent response to the Sr-
supplemented formulations, in particular after 14 days culture; the IL10 expression 
increases with increasing concentration of added SrCl2 (Figure 6b). Interestingly, these 
results could be correlated with the changes in the proteomic patterns observed using 
LC-MS/MS analysis. Ali K et al. have found an increase in plasma levels of pro-
inflammatory cytokines, such as TNF-α, in APOE-knockout mice [52]. This is consistent 
with the reduction in the TNF-α expression observed on the material with a stronger 
affinity to APOE. The enhanced expression of IL10, a cytokine generated by M2 
macrophage switch, concurs with an increased affinity to proteins like APOE and 
VTNC, favouring the macrophage differentiation from pro-inflammatory M1 to anti-
inflammatory M2 phenotype [41,48]. 
 
5. Conclusion 
In summary, incorporation of SrCl2 into a hybrid sol-gel biomaterial significantly 
changes its physico-chemical properties (hydrophilicity and roughness) and affects 
protein affinity profiles and cell responses. The LC-MS/MS analysis revealed that the 
addition of Sr modified significantly the attachment profiles of proteins involved in the 
inflammation and coagulation processes. Remarkably, it increased the adsorption of 
APOE and VTNC, proteins related to osteogenic and anti-inflammatory processes, onto 
the biomaterial surface. Both the osteoblast and macrophage cells showed SrCl2 dose-
dependent behaviour. An increase in the gene expression of osteogenic markers ALP 
and TGF-β was observed in the MC3T3-E1 cells. While, a decrease in the expression 
of inflammation marker TNF-α and an increase in anti-inflammatory IL-10 expression 
were seen in the macrophage cell line. The proteomic and gene expression analyses 
showed that the introduction of Sr into the biomaterials might improve their osteogenic 
and anti-inflammatory potential.  
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